Integration of National AIDS Control Program and Pharmacovigilance Program of India-Antiretroviral Drugs safety coactions in India
Journal: International Journal of HIV/AIDS and Research (IJHR) (Vol.02, No. 04)Publication Date: 2015-05-05
Authors : Kalaiselvan V; Prasad T; Vivek D; Gyanendra Nath Singh; Rathore A.S; Rewari B.B;
Page : 37-38
Keywords : World Health Organization (WHO); Pharmacovigilance Program; Anti-Retroviral Therapy (ART) drugs;
Abstract
This letter describes the initiatives taken by Indian Pharmacopoeia Commission (IPC) in monitoring safety of Anti-Retroviral Therapy (ART) drugs [1, 2, 3]. The Collaboration between National AIDS control organization (NACO) & Pharmacovigilance Program of India (PvPI) is aimed to work with periphery ART centres to monitor the safety of ART drugs & also to initiate the Cohort Event Monitoring (CEM) thus to perform the benefitrisk assessment of ART drugs, however there are some technical & operational issues in implementing the program & identifying the risk related to ART drugs. Pharmacovigilance is the science and activities relating to detection, assessment, understanding and prevention adverse effects or any other possible drug related problems
Other Latest Articles
- MACHIAVELLIANISM AS A PERSONAL FEATURE OF LEADER
- METHODOLOGICAL FRAMEWORK OF RESEARCH OF PROFESSIONAL SELF-IDENTITY AT TEACHERS OF HIGHER EDUCATION
- THE ORIGIN OF MUSICAL INSTRUMENTARIUM (ON THE EXAMPLE OF THE UZBEK CHANG)
- THE ROLE OF I.K. AIVAZOVSKY IN THE ART OF MARINE PAINTER EMMANUIL MAGDESYAN
- Rapidly Progressive Multicentric Castleman’s Disease in Patient with Acute Retroviral Syndrome: A Case Report
Last modified: 2017-05-31 18:18:59